Robert W. Baird Boosts Longboard Pharmaceuticals (NASDAQ:LBPH) Price Target to $60.00
Longboard Pharmaceuticals (NASDAQ:LBPH – Free Report) had its target price hoisted by Robert W. Baird from $36.00 to $60.00 in a research report report published on Thursday morning, Benzinga reports. They currently have an outperform rating on the stock. Other research analysts have also issued reports about the company. B. Riley upped their price target […]
More Stories
Maduro and His Wife Indicted in US Federal Court
By T.J. Muscaro Nicolás Maduro and his wife, Cilia Flores, were indicted in the Southern District of New York, U.S....
Swiss Prosecutors Investigate Bar Managers After Deadly Ski Resort Fire
By Jacki Thrapp Swiss authorities opened a criminal investigation into two bar managers after a fire at a ski resort...
US Agencies Terminate ‘Wasteful’ Contracts Worth $1.6 Billion Ceiling Value: DOGE
By Naveen Athrappully Over the past three days, federal agencies have terminated and descoped 55 “wasteful” contracts with a ceiling...
AI Spending Fuels High Tech Growth in 2025, But a Crucial Test Lies Ahead
By Panos Mourdoukoutas Heavy investment in artificial intelligence (AI) infrastructure accounted for the majority of IT spending in 2025. It...
DOJ Eyes Minnesota’s ‘Vouching’ System for Voter Registration, Demands Records
By Jill McLaughlin The Department of Justice’s (DOJ) civil rights division demanded voter registration records from Minnesota on Jan. 2, saying...
FBI Thwarts ISIS-Inspired New Year’s Eve Terror Plot in North Carolina
By Jackson Richman The FBI said it foiled an ISIS-inspired New Year’s Eve terror attack in North Carolina. Suspect Christian...